Source: BioCentury

Alzheon: Amid Alzheon Alzheimer's setback, PIs see new surrogate endpoint

APR 02, 2025 | 5:02 PM PDT | BIOCENTURY | PRODUCT DEVELOPMENTAMID ALZHEON ALZHEIMER'S SETBACK, PIS SEE NEW SURROGATE ENDPOINTBY But study's PIs argue for hippocampal volume as a new surrogate endpoint https://www.biocentury.com/article/655517/amid-alzheon-alzheimer-s-setback-pis-see-new-surrogate-endpoint© 2025 BioCentury Inc. All Rights Reserved

Read full article »
Alzheon's Competitors | Alzheon's News | Alzheon's Financials
Stay up-to-date with the latest news on Alzheon
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Martin Tolar's photo - President & CEO of Alzheon

President & CEO

Martin Tolar

CEO Approval Rating

84/100

Read more
Stay up-to-date with the latest news on Alzheon